ID23150A - Metoda penguatan aktivitas antitumor obat-obatan gubal, komposisi yg mengandung abat gubal penguat aktivitas antitumor, metoda utk mengevaluasi kemanjuran dg perlakuan obat gubal, dn metoda utk mengevaluasi kemanjuran antitumor dari obat gubal - Google Patents

Metoda penguatan aktivitas antitumor obat-obatan gubal, komposisi yg mengandung abat gubal penguat aktivitas antitumor, metoda utk mengevaluasi kemanjuran dg perlakuan obat gubal, dn metoda utk mengevaluasi kemanjuran antitumor dari obat gubal

Info

Publication number
ID23150A
ID23150A IDP990871D ID990871D ID23150A ID 23150 A ID23150 A ID 23150A ID P990871 D IDP990871 D ID P990871D ID 990871 D ID990871 D ID 990871D ID 23150 A ID23150 A ID 23150A
Authority
ID
Indonesia
Prior art keywords
pregnancy
utk
activities
antitumor
methods
Prior art date
Application number
IDP990871D
Other languages
English (en)
Indonesian (id)
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of ID23150A publication Critical patent/ID23150A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IDP990871D 1998-09-17 1999-09-17 Metoda penguatan aktivitas antitumor obat-obatan gubal, komposisi yg mengandung abat gubal penguat aktivitas antitumor, metoda utk mengevaluasi kemanjuran dg perlakuan obat gubal, dn metoda utk mengevaluasi kemanjuran antitumor dari obat gubal ID23150A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (1)

Publication Number Publication Date
ID23150A true ID23150A (id) 2000-03-23

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990871D ID23150A (id) 1998-09-17 1999-09-17 Metoda penguatan aktivitas antitumor obat-obatan gubal, komposisi yg mengandung abat gubal penguat aktivitas antitumor, metoda utk mengevaluasi kemanjuran dg perlakuan obat gubal, dn metoda utk mengevaluasi kemanjuran antitumor dari obat gubal

Country Status (19)

Country Link
JP (1) JP2000159682A (nl)
KR (1) KR20000023206A (nl)
CN (1) CN1255376A (nl)
AU (1) AU4486299A (nl)
BE (1) BE1012725A5 (nl)
CA (1) CA2282234A1 (nl)
DE (1) DE19944695A1 (nl)
DK (1) DK199901235A (nl)
ES (1) ES2155802B1 (nl)
FR (2) FR2783426A1 (nl)
GB (2) GB9920710D0 (nl)
ID (1) ID23150A (nl)
IL (1) IL131722A0 (nl)
IS (1) IS5183A (nl)
IT (1) IT1307267B1 (nl)
NL (2) NL1013049C2 (nl)
NO (1) NO994463L (nl)
SE (2) SE9903307L (nl)
SG (1) SG76631A1 (nl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
TWI330533B (en) 2002-05-15 2010-09-21 Bhn Co Ltd Composition for angiogenesis inhibition, neoplasm inhibition,or immunostimulation
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
WO2006030750A1 (ja) 2004-09-17 2006-03-23 Ssi Co., Ltd. 乳癌を抑制するカワリハラタケ抽出物
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
WO2011014729A1 (en) * 2009-07-31 2011-02-03 Yukiguni Maitake Co., Ltd. Maitake mushroom coffee
WO2011081024A1 (ja) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
NL1019705C2 (nl) 2002-03-26
GB9920710D0 (en) 1999-11-03
GB9921387D0 (en) 1999-11-10
SE0100195L (sv) 2001-01-24
DE19944695A1 (de) 2000-03-30
SE9903307D0 (sv) 1999-09-16
NO994463D0 (no) 1999-09-15
FR2788697A1 (fr) 2000-07-28
NO994463L (no) 2000-03-20
ITTO990784A1 (it) 2001-03-14
IS5183A (is) 2000-03-17
SE9903307L (sv) 2000-03-18
BE1012725A5 (fr) 2001-02-06
SG76631A1 (en) 2000-11-21
GB2341800A (en) 2000-03-29
NL1013049A1 (nl) 2000-03-21
IL131722A0 (en) 2001-03-19
NL1013049C2 (nl) 2002-01-11
JP2000159682A (ja) 2000-06-13
ITTO990784A0 (it) 1999-09-14
ES2155802A1 (es) 2001-05-16
ES2155802B1 (es) 2001-12-01
FR2783426A1 (fr) 2000-03-24
NL1019705A1 (nl) 2002-01-29
CA2282234A1 (en) 2000-03-17
SE0100195D0 (sv) 2001-01-24
CN1255376A (zh) 2000-06-07
DK199901235A (da) 2000-03-18
KR20000023206A (ko) 2000-04-25
AU4486299A (en) 2000-03-30
IT1307267B1 (it) 2001-10-30

Similar Documents

Publication Publication Date Title
ID23150A (id) Metoda penguatan aktivitas antitumor obat-obatan gubal, komposisi yg mengandung abat gubal penguat aktivitas antitumor, metoda utk mengevaluasi kemanjuran dg perlakuan obat gubal, dn metoda utk mengevaluasi kemanjuran antitumor dari obat gubal
EA200000814A1 (ru) Фармацевтическая композиция топирамата
HUP0301046A3 (en) Quinazoline derivatives for the treatment of tumours, process for their preparation and pharmaceutical compositions containing them
HUP0402588A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
FR2816938B1 (fr) Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
MA27410A1 (fr) Nouveaux composes pyridopyrimidinone leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA24484A1 (fr) Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant .
PL393385A1 (pl) Sposób modyfikacji i rekrystalizacji pokroju kryształów substancji leczniczej, kryształy mykofenolanu sodu i ich zastosowanie oraz kompozycja farmaceutyczna
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
HK1076095A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
DE60202603D1 (de) 8-(c-beta-d-glucopyranosyl)-7,3',4'-trihydroxyflavone, verfahren zur isolation aus pterocarpus marsupium und pharmazeutische zusammensetzung zur behandlung von diabetes
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
WO2002067771A3 (en) Chemokine receptors and disease
HUP0104002A3 (en) Alpha2-antagonists tricyclic delta3-piperidines, process for their producing the pharmaceutical compositions containing them and their use as medicament
FR2845388B1 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
EP1532979A4 (en) DRUG COMPOSITION FOR REGULATING GLYCEMIA
AU8893098A (en) Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting
MA26606A1 (fr) Derives de 5-desoxycytidine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation.
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives